跳至主要内容
临床试验/CTRI/2025/02/080661
CTRI/2025/02/080661尚未招募不适用

Role of Invididualized Homoeopathic Medicine in Bronchial Asthma in cases of Young and Middle Age Group Patients.

Dr Vikas Chaudhary1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年2月18日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
1) it is expected that individualized homoeopathic Medicines selected will prove effective in the management of bronchial asthma.

研究概览

简要总结

The present study is going to assess the role of individualized homoeopathic medicine in improving the symptoms of bronchial asthma and improvement in their healthy lifestyle..

A detailed case taking will be done using a standard homoeopathic case taking proforma, and after the diagnosis has been made the patient will be asked to fill the Asthma Control Test form for evaluation of the degree of disease, and maintaining all the previous and subsequent scores.

The individualized homoeopathic medicine will be selected on the basis of repertorial evaluation. The potency and dose will be selected according to the individual case and follow ups will be done in every 15 days. The Quality of life will also be assessed by the use of Modified Naranjo Algorithm.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • The sample includes patient of 18 to 60 years old age group of both sexes.
  • Patient fulfilling GINA(Global Initiative for Asthma) diagnostic criteria.
  • Informed and written consent.

排除标准

  • Patients below the age of 18 and over the age of
  • Chronic systemic illness (e.g. Epilepsy, digestive, cardiovascular, renal and endocrine disorders.) 3) Use of medications for some other conditions or disease.
  • Patients with developed complications of asthma.

结局指标

主要结局

1) it is expected that individualized homoeopathic Medicines selected will prove effective in the management of bronchial asthma.

时间窗: 4weeks, 24weeks

2) The study will determine whether the quality of life of patients suffering From asthma can be improved by using individualized Homoeopathic medicine.

时间窗: 4weeks, 24weeks

次要结局

  • 1. If the results would be positive than a certain group of medicines can be Found out which would frequently prove useful in management of bronchial asthma(2.the study will go into public domain & will be beneficial for public.)

研究者

发起方
Dr Vikas Chaudhary
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Vikas Chaudhary

State National Homoeopathic Medical College Lucknow

研究点 (1)

Loading locations...

相似试验